This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Medquímica Indústria Farmacêutica S.A.
Medquímica Indústria Farmacêutica S.A., commonly referred to as Medquímica, is a prominent player in the pharmaceutical industry, headquartered in Brazil. Established in 1975, the company has made significant strides in the development and production of high-quality pharmaceutical products, primarily focusing on prescription medications and over-the-counter solutions. With a strong presence across various regions in Brazil, Medquímica is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of therapeutic areas, particularly in analgesics, anti-inflammatories, and antibiotics, distinguished by their efficacy and safety profiles. Medquímica's dedication to research and development has positioned it as a trusted name in the market, achieving notable milestones in product launches and regulatory approvals.
DitchCarbon Score
How does Medquímica Indústria Farmacêutica S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medquímica Indústria Farmacêutica S.A.'s score of 66 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medquímica Indústria Farmacêutica S.A., headquartered in Brazil, currently does not report specific carbon emissions data for the most recent year. The company is a current subsidiary of Lupin Limited, which influences its climate commitments and emissions reporting. As part of its climate strategy, Medquímica inherits various initiatives from Lupin Limited, including commitments to the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements have not been disclosed for Medquímica itself. The absence of direct emissions data suggests that Medquímica is still in the process of establishing its own climate metrics or may rely on the broader corporate family’s initiatives for guidance. The company's climate commitments are aligned with those of Lupin Limited, which may include overarching goals for emissions reduction and sustainability practices. In summary, while Medquímica Indústria Farmacêutica S.A. does not currently provide specific emissions figures, it is positioned within a framework of climate initiatives inherited from Lupin Limited, reflecting a commitment to addressing climate change through corporate responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 103,887,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 371,883,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 680,968,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medquímica Indústria Farmacêutica S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
